Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SARS-CoV-2 Seroconversion Study Among GHdC Staff Members

NCT04723290 is registered in ClinicalTrials.gov with Grand Hôpital de Charleroi as lead sponsor.

NCT NCT04723290
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04723290 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SARS-CoV-2 Seroconversion Study Among GHdC Staff Members
Lead sponsor
Grand Hôpital de Charleroi
Phase
Not applicable
Overall status
Completed
Start date
June 20, 2020
Completion date
December 31, 2020
Enrollment
2,817 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid19